DrugsControl Media Services
DrugsControl.org

News Detail

How Asian pharma suppliers cash in on Ozempic copies (01-11-2024)

SHANGHAI, 1 NOV 2024: Just over a year ago, New Zealand customs officials started to intercept batches of injectable medications labelled Fitaro and Orsema, developed by a little-known Bangladeshi drugmaker, Incepta Pharmaceuticals.

 

The injectable pens, 14 ......
View Details

Source : Reuters
Bangladeshi drugs Ozempic semaglutide Novo Nordisk weight-loss treatments

Related News